PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

 126.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 141.20
  • 52 Week Low: 106.40
  • Currency: UK Pounds
  • Shares Issued: 244.38m
  • Volume: 859,650
  • Market Cap: £307.91m
  • Beta: 0.01

PRTC Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

1 Day Chart (28-08-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2114.8% -1446.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 84.8 n/a
Pr/Book 1.3  
Latest F'cast
Revenue n/a 12.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

PRTC Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 17.39 (58.95) (21.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 15.62 (92.78) (18.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 3.33 (36.10) (24.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-24 4.66 23.77 21.00¢ 9.7 n/a n/a n/a 0.0%
31-Dec-25 4.66 (110.93) (46.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

PRTC Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 7.10 (102.67) (39.78)p n/a n/a n/a n/a 0.0%
31-Dec-27 13.47 (88.23) (29.14)p n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

PRTC Company Announcements

Holding(s) in Company 28-Aug-2026 07:00 RNS
PDMR Notification RSU Vesting 18-Aug-2026 17:30 RNS
Total Voting Rights 03-Aug-2026 07:00 RNS

PRTC ShareCast News

PureTech appoints Robert Lyne as permanent CEO 18-Dec-2025 ShareCast
PureTech Health contract revenues surge, cuts co... 28-Aug-2025 ShareCast
PureTech launches respiratory development vehicl... 12-Aug-2025 ShareCast

Latest PRTC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 126.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 141.20
52 Week Low 106.40
Volume 859,650
Shares Issued 244.38m
Market Cap £307.91m
Beta 0.01

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average
95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average
Price Trend
53.88% below the market average53.88% below the market average53.88% below the market average53.88% below the market average53.88% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
23.61% below the market average23.61% below the market average23.61% below the market average23.61% below the market average23.61% below the market average
37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 28-Aug-2026

Time Volume / Share Price
16:43 10,000 @ 127.20p
16:35 244,998 @ 126.00p
16:35 1,234 @ 126.00p
16:35 1,077 @ 126.00p
16:35 2,771 @ 126.00p

PRTC Key Personnel

CEO Robert Lyne

Top of Page